Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in Singapore
British Journal of Clinical Pharmacology · 05.11.2026
DOI: 10.1002/bcp.70889 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 05.11.2026. Verfasst von Elaine Ah Gi Lo und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National University Hospital, Singapore. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National University Health System (NUHS) - Strategic Research Funds, Precision Health Research, Singapore (PRECISE), National Research Foundation, Singapore (NRF).
Abstract (Originalsprache)
Aims
Pre‐emptive pharmacogenomics (PPGx) testing holds promise for optimizing drug therapy, but uptake remains limited in Asia. This pilot study aimed to assess the feasibility of PPGx uptake into clinical practice and its impact on prescribing in an Asian healthcare setting.
Methods
A prospective, multicentre pilot study was conducted to pre‐emptively genotype 16 pharmacogenes. Results were integrated into electronic health records, alongside deployment of clinical decision support (CDS) tools for 31 drug–gene pairs. A pharmacogenomics drug information service and digital platforms were also developed.
Results
All 2492 participants carried ≥1 actionable variant (median: 5, range: 1–11). Across four institutions within one cluster, 1046 out of 2238 (46.7%) patients were prescribed ≥1 drug with pharmacogenetic association, and of those, 460 (44%) had genotypes linked to undesirable drug responses. Among 285 interruptive CDS alerts, 69 (24.2%) led to prescription modifications. Acceptance was higher for new prescriptions (50.0% vs . 17.3%, p < 0.001), in outpatient settings (31.0% vs . 7.3%, p < 0.001) and among consultants (57.1% vs . other designations 5–27.3%, p < 0.001). The drug information service received 137 enquiries, while 471 and 151 patients accessed the app and web‐based platforms respectively.
Conclusions
PPGx testing and genotype‐guided prescribing are feasible in Singapore. Widespread adoption requires leadership support, robust informatics infrastructure, clinician engagement and sustainable funding.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, National University Hospital, Singapore.
- Department of Pharmacy, Ng Teng Fong General Hospital, Singapore.
- Department of Pharmacy, Alexandra Hospital, Singapore.
- National University Health System Pharmacy, Singapore.
- Division of Pharmacy, Tan Tock Seng Hospital, Singapore.
- Department of Pharmacy, Khoo Teck Puat Hospital, Singapore.
ORCID-Profile: Elaine Ah Gi Lo, Dennis Chua, Huang En Toh, Evelyn Shi Jie Tan, Amanda Lay Ying Lim, Christina Jiun Yu Tan, Siok Ying Lee, Jing Wen Oh, Pei Shieen Wong, Lawrence Siu-Chun Law, Jishana Farhad Abdul Naseer, Humphrey Hean Teik Ko, Boon Cher Goh, Benjamin Yong-Qiang Tan, Yi Min Wan, Fathima Ashna Nastar, Khai Pang Leong, Liuh Ling Goh, Teck Choon Tan, Syed Saqib Imran, Kaavya Narasimhalu, Joanne Ngeow, Kee Yuan Ngiam, Patrick Tan, Ee Shien Tan, Doreen Low, Hwee Lin Wee, E Shyong Tai, Jared D'Souza
Förderung
- National University Health System (NUHS) - Strategic Research Funds
- Precision Health Research, Singapore (PRECISE)
- National Research Foundation, Singapore (NRF)
- Singapore Ministry of Health (MOH)
Zitieren
APA
Lo, E. A. G., Chua, H. M., Chua, D., Toh, H. E., Tan, E. S. J., Wang, G., Gwee, M. Y., Lim, A. L. Y., Tan, C. J. Y., Lee, S. Y., Oh, J. W., Wong, P. S., Law, L. S., Lim, K. J., Naseer, J. F. A., Ko, H. H. T., Goh, B. C., Tan, B. Y., Wan, Y. M., …, & D'Souza, J. (2026). Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in Singapore. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70889
Vancouver
Lo EAG, Chua HM, Chua D, Toh HE, Tan ESJ, Wang G, et al. Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in Singapore. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70889
BibTeX
@article{Lo2026,
author = {Lo, Elaine Ah Gi and Chua, Hui Min and Chua, Dennis and Toh, Huang En and Tan, Evelyn Shi Jie and Wang, Golda and Gwee, Min Yi and Lim, Amanda Lay Ying and Tan, Christina Jiun Yu and Lee, Siok Ying and Oh, Jing Wen and Wong, Pei Shieen and Law, Lawrence Siu-Chun and Lim, Ken Juin and Naseer, Jishana Farhad Abdul and Ko, Humphrey Hean Teik and Goh, Boon Cher and Tan, Benjamin Yong-Qiang and Wan, Yi Min and Nastar, Fathima Ashna and Taiju, Rangpa and Leong, Khai Pang and Goh, Liuh Ling and Tan, Teck Choon and Imran, Syed Saqib and Narasimhalu, Kaavya and Ngeow, Joanne and Zhang, Zewen and Ngiam, Kee Yuan and Tan, Patrick and Tan, Ee Shien and Low, Doreen and Wee, Hwee Lin and Tai, E Shyong and D'Souza, Jared},
title = {Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in Singapore},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70889}
}
EUVIMED